FDA Commissioner Launches Controversial Expert Panels Under New HHS Leadership

FDA Commissioner Marty Makary has established a series of ad hoc expert panels to discuss various health topics, raising concerns about transparency and conflicts of interest. These panels, which have addressed issues including talc safety, antidepressants during pregnancy, and hormone therapy for menopause, feature participants with financial interests in the subjects and views that some critics consider outside mainstream scientific consensus. Former FDA officials have expressed concern that these meetings may circumvent federal rules on conflicts of interest and transparency.